R-Biopharm Gets CE Mark for SARS-CoV-2 PCR Test

Jun 17, 2020

|

NEW YORK – R-Biopharm of Darmstadt, Germany, has obtained the CE mark for its SARS-CoV-2 real-time RT-PCR test.

The company's Rida Gene SARS-CoV-2 test is designed for the qualitative detection of SARS-CoV-2 RNA from throat and nasopharyngeal swabs of individuals with respiratory symptoms. It runs on the Roche LightCycler 480II and is intended for use by professionals in hospital, reference, private, and state laboratories.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Stricter Vaccine Standards

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

Another Trial to Ramp Up

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Few Billion More

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

Genome Research Studies on SARS-CoV-2 Super-Spreaders, Pan-Cancer Epigenetics, More

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.

Featured White Papers

Increased DNA Yield and Reduced PCR Duplicates Using the Ionic System

Isotachophoresis Improves Nucleic Acid Extraction and Purification from FFPE Samples

A Real-Time-Assay for the fast and gel-free detection of Rhesus Weak D Type 1/1.1 to Type 3

Fast Real-Time PCR Detection of HLA-B*27 Directly from Blood Using a Specialized Stabilizing Reagent

Sep

30

Featured Webinar

Moving from Non-Invasive Prenatal Screening to Prenatal Diagnostics: An Expert Panel Discussion

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care.

Oct

01

Featured Webinar

Immune Repertoire Sequencing to Uncover SARS-CoV-2-Specific T Cell Responses and Dynamics

T cells are the adaptive immune system’s first responders to any virus, circulating in the blood to detect and quickly multiply to attack the virus, and also support the development of antibodies by B cells.

Oct

08

Featured Webinar

Novel Applications of RNA-based Precision Oncology: From Drug Tolerability to Immunogenomics

This webinar, Part 3 of the “Advances in RNA-based Biomarker Development for Precision Oncology” webinar series sponsored by GeneCentric Therapeutics, will discuss novel and emerging applications of RNA-based genomic analysis in precision oncology, form characterizing the tumor microenvironment to informing the development of immuno-oncology treatments.

Oct

14

Featured Webinar

Application of ctDNA Analysis to Detect MRD and Predict Recurrence in Colorectal Cancer

Circulating tumor DNA (ctDNA) can allow clinicians and researchers to better understand which patients are at high risk of recurrence and should be offered intensified chemotherapy or selected for clinical trials.

Menu

R-Biopharm Gets CE Mark for SARS-CoV-2 PCR Test

To read the full story....

Breaking News

CRISPR Screen Uncovers Genes That Help Cancer Cells Evade Immune System

Pale Melanoma Susceptibility Linked to Albinism-Related Genes

Vela Diagnostics Receives Second FDA Emergency Use Authorization for SARS-CoV-2 Molecular Test

Centogene Reports 13 Percent Decline in Q2 Revenues

Metabolon Closes $72M in Debt and Equity Funding

Becton Dickinson Submits Premarket Approval Supplement to FDA for HPV Assay

The Scan

Stricter Vaccine Standards

Another Trial to Ramp Up

Few Billion More

Genome Research Studies on SARS-CoV-2 Super-Spreaders, Pan-Cancer Epigenetics, More

Featured White Papers

Moving from Non-Invasive Prenatal Screening to Prenatal Diagnostics: An Expert Panel Discussion

Immune Repertoire Sequencing to Uncover SARS-CoV-2-Specific T Cell Responses and Dynamics

Novel Applications of RNA-based Precision Oncology: From Drug Tolerability to Immunogenomics

Application of ctDNA Analysis to Detect MRD and Predict Recurrence in Colorectal Cancer

What's Popular?

Vela Diagnostics Receives Second FDA Emergency Use Authorization for SARS-CoV-2 Molecular Test

Becton Dickinson Submits Premarket Approval Supplement to FDA for HPV Assay

Centogene Reports 13 Percent Decline in Q2 Revenues

FDA Grants Emergency Use Authorization for GK Pharmaceuticals Coronavirus Test

Qiagen Acquires Remaining Stake in NeuMoDx Molecular for $248M

Sponsorships